Carmel Jennings has extensive experience in bioprocess development, currently serving as Team Lead in Large Molecule Process Development at APC Ltd since April 2016. Prior to this role, Carmel worked as a BioProcess Consultant at FinVector Vision Therapies Oy from February 2015 to March 2016, and as Bioprocess Scientist at Pfizer from September 2006 to November 2014, focusing on upstream and downstream process development including cell culture and protein manufacturing. Earlier experience includes a position as Scientist at the Ontario Institute for Cancer Research, where Carmel specialized in the expression, induction, and purification of Hamster Prion Protein. Carmel holds a Bachelor of Science (BSc Hons) degree in Biotechnology from the University of Galway, completed in 2006.